Literature DB >> 19963380

Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

Onica Legendre1, Stevan Pecic, Sandeep Chaudhary, Sarah M Zimmerman, William E Fantegrossi, Wayne W Harding.   

Abstract

The naturally occurring aporphine alkaloid nantenine, has been shown to antagonize behavioral and physiological effects of MDMA in mice. We have synthesized (+/-)-nantenine via an oxidative cyclization reaction with PIFA and evaluated its binding profile against a panel of CNS targets. To begin to understand the importance of the chiral center of nantenine with regards to its capacity to antagonize the effects of MDMA in vivo, (R)- and (S)-nantenine were prepared and evaluated in a food-reinforced operant task in rats. Pretreatment with either nantenine enantiomer (0.3mg/kg ip) completely blocked the behavioral suppression induced upon administration of 3.0mg/kg MDMA. (+/-)-Nantenine displayed high affinity and selectivity for the alpha(1A) adrenergic receptor among several other receptors suggesting that this alpha(1) subtype may be significantly involved in the anti-MDMA effects of the enantiomers. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963380      PMCID: PMC2818532          DOI: 10.1016/j.bmcl.2009.11.053

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

1.  Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.

Authors:  Michael A Taffe; Christopher C Lay; Stefani N Von Huben; Sophia A Davis; Rebecca D Crean; Simon N Katner
Journal:  Drug Alcohol Depend       Date:  2005-11-11       Impact factor: 4.492

2.  Structure-activity relationship on (+/-)-nantenine derivatives in antiserotonergic activities in rat aorta.

Authors:  Bachtiar Indra; Kimihiro Matsunaga; Osamu Hoshino; Masaji Suzuki; Hiromichi Ogasawara; Masaji Ishiguro; Yasushi Ohizumi
Journal:  Can J Physiol Pharmacol       Date:  2002-03       Impact factor: 2.273

3.  Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Authors:  M E Liechti; M R Saur; A Gamma; D Hell; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2000-10       Impact factor: 7.853

4.  Structure-activity relationship studies with (+/-)-nantenine derivatives for alpha1-adrenoceptor antagonist activity.

Authors:  Bachtiar Indra; Kimihiro Matsunaga; Osamu Hoshino; Masaji Suzuki; Hiromichi Ogasawara; Yasushi Ohizumi
Journal:  Eur J Pharmacol       Date:  2002-02-22       Impact factor: 4.432

5.  Microwave-Assisted Direct Biaryl Coupling: First Application to the Synthesis of Aporphines.

Authors:  Sandeep Chaudhary; Stevan Pecic; Onica Legendre; Wayne W Harding
Journal:  Tetrahedron Lett       Date:  2009-05-20       Impact factor: 2.415

6.  3,4-Methylenedioxymethamphetamine, serotonin and memory.

Authors:  G A Ricaurte; A L Markowska; G L Wenk; G Hatzidimitriou; J Wlos; D S Olton
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

7.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

Authors:  J H Krystal; L H Price; C Opsahl; G A Ricaurte; G R Heninger
Journal:  Am J Drug Alcohol Abuse       Date:  1992       Impact factor: 3.829

8.  Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Authors:  M E Liechti; M A Geyer; D Hell; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

9.  Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.

Authors:  S Bexis; J R Docherty
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

10.  Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.

Authors:  Jon E Sprague; Robert E Brutcher; Edward M Mills; David Caden; Daniel E Rusyniak
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

View more
  9 in total

1.  Cytotoxicity of aporphines in human colon cancer cell lines HCT-116 and Caco-2: an SAR study.

Authors:  Shashikanth Ponnala; Sandeep Chaudhary; Antonio González-Sarrias; Navindra P Seeram; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2011-06-15       Impact factor: 2.823

2.  Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.

Authors:  Stevan Pecic; Pooja Makkar; Sandeep Chaudhary; Boojala V Reddy; Hernan A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2010-06-20       Impact factor: 3.641

3.  Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.

Authors:  Shashikanth Ponnala; Junior Gonzales; Nirav Kapadia; Hernan A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2014-03-04       Impact factor: 2.823

4.  New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.

Authors:  Sandeep Chaudhary; Shashikanth Ponnala; Onica Legendre; Junior A Gonzales; Hernán A Navarro; Wayne W Harding
Journal:  Bioorg Med Chem       Date:  2011-08-18       Impact factor: 3.641

5.  C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.

Authors:  Nirav Kapadia; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2015-07-11       Impact factor: 2.823

6.  A New Route to Azafluoranthene Natural Products via Direct Arylation.

Authors:  Shashikanth Ponnala; Wayne W Harding
Journal:  European J Org Chem       Date:  2013-01-03

7.  Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists.

Authors:  Hui Li Heng; Chin Fei Chee; Sek Peng Chin; Yifan Ouyang; Hao Wang; Michael J C Buckle; Deron R Herr; Ian C Paterson; Stephen W Doughty; Noorsaadah Abd Rahman; Lip Yong Chung
Journal:  Medchemcomm       Date:  2018-02-26       Impact factor: 3.597

8.  Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine.

Authors:  Jiao-Lan Qin; Ting Meng; Zhen-Feng Chen; Xiao-Li Xie; Qi-Pin Qin; Xiao-Ju He; Ke-Bin Huang; Hong Liang
Journal:  Oncotarget       Date:  2017-07-26

Review 9.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.